Goodwin Procter LLP advised BeiGene Ltd on the deal. BeiGene Ltd. closed the pricing of a registered direct offering of 145,838,979 at a purchase price of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
